300573 兴齐眼药
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)10.60214.80714.61519.21414.069
总资产报酬率 ROA (%)8.24612.61112.20214.6809.678
投入资产回报率 ROIC (%)9.55514.35713.97317.46912.241

边际利润分析
销售毛利率 (%)78.16477.37378.74478.08773.133
营业利润率 (%)23.40618.84220.01124.16515.354
息税前利润/营业总收入 (%)22.34617.63218.05224.28915.796
净利润/营业总收入 (%)18.98616.35616.93720.34313.571

收益指标分析
经营活动净收益/利润总额(%)98.562101.219100.82097.623100.509
价值变动净收益/利润总额(%)-0.0120.0000.0001.2910.000
营业外收支净额/利润总额(%)-4.200-4.350-7.010-1.994-3.117

偿债能力分析
流动比率 (X)1.7573.4805.6753.6891.385
速动比率 (X)1.4632.9574.8733.3431.063
资产负债率 (%)27.78216.49912.93620.2950.281
带息债务/全部投入资本 (%)10.9730.670-3.9782.8643.383
股东权益/带息债务 (%)775.03714,211.811-2,488.6923,211.5262,627.974
股东权益/负债合计 (%)259.940506.080673.062392.723251.135
利息保障倍数 (X)-191.066-41.567-27.88540.71117.420

营运能力分析
应收账款周转天数 (天)42.62936.97833.42538.58853.637
存货周转天数 (天)131.900140.014145.398128.372144.149